Melissa Eastgate

581 total citations
25 papers, 195 citations indexed

About

Melissa Eastgate is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Melissa Eastgate has authored 25 papers receiving a total of 195 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Melissa Eastgate's work include CAR-T cell therapy research (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immunotherapy and Immune Responses (4 papers). Melissa Eastgate is often cited by papers focused on CAR-T cell therapy research (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immunotherapy and Immune Responses (4 papers). Melissa Eastgate collaborates with scholars based in Australia, Hong Kong and China. Melissa Eastgate's co-authors include Amitesh Roy, Frédéric Triebel, Christian Mueller, Chrystelle Brignone, Andrew Haydon, Victoria Atkinson, Adnan Khattak, Prashanth Prithviraj, Matthew Burge and David Wyld and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Melissa Eastgate

21 papers receiving 192 citations

Peers

Melissa Eastgate
Rangarirai Makuku Iran
Alexandra C. Istl United States
Manli Miao China
Cyril Lervat France
Sarah Wall United States
Scott Maffett United States
Zhi-ling Yang China
María Velez United States
Emily S. Andersen United States
Maria Koutsaki Greece
Rangarirai Makuku Iran
Melissa Eastgate
Citations per year, relative to Melissa Eastgate Melissa Eastgate (= 1×) peers Rangarirai Makuku

Countries citing papers authored by Melissa Eastgate

Since Specialization
Citations

This map shows the geographic impact of Melissa Eastgate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Eastgate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Eastgate more than expected).

Fields of papers citing papers by Melissa Eastgate

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Eastgate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Eastgate. The network helps show where Melissa Eastgate may publish in the future.

Co-authorship network of co-authors of Melissa Eastgate

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Eastgate. A scholar is included among the top collaborators of Melissa Eastgate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Eastgate. Melissa Eastgate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xia, Qing, Sameera Senanayake, Sanjeewa Kularatna, et al.. (2024). Cost-effectiveness analysis of microwave ablation versus robot-assisted partial nephrectomy for patients with small renal masses in Australia. Urologic Oncology Seminars and Original Investigations. 43(1). 62.e15–62.e26.
3.
Hapgood, Greg, Kate Hill, Satomi Okano, et al.. (2024). Catheter-related thrombosis in adults with cancer: a secondary analysis of a prospective randomized controlled trial. Journal of Thrombosis and Haemostasis. 23(2). 627–634. 1 indexed citations
4.
Lau, Peter K. H., S.J. Harris, Melissa Eastgate, et al.. (2023). CHARLI: A phase Ib/II trial of ipilimumab-nivolumab-denosumab or nivolumab-denosumab in patients with unresectable stage III and IV melanoma.. Journal of Clinical Oncology. 41(16_suppl). 9525–9525. 1 indexed citations
5.
Brown, Teresa, et al.. (2022). Investigating the dietary knowledge, attitudes, and beliefs of Australian patients with cancer. Journal of Human Nutrition and Dietetics. 36(3). 612–621. 2 indexed citations
6.
Dzienis, Marcin, et al.. (2022). Toxicity and response to ipilimumab and nivolumab in older patients with metastatic melanoma: A multicentre retrospective analysis. Pigment Cell & Melanoma Research. 35(6). 587–594. 3 indexed citations
7.
Ahern, Elizabeth, Natasha Roberts, Bryan Chan, et al.. (2021). Semiqualitative research protocol to explore cancer care workforce perceptions of the health system response to COVID-19 preparations in Southeast Queensland, Australia. BMJ Open. 11(5). e044655–e044655. 2 indexed citations
8.
Molassiotis, Alex, Teresa Brown, Huilin Cheng, et al.. (2021). The effects of a family-centered psychosocial-based nutrition intervention in patients with advanced cancer: the PiCNIC2 pilot randomised controlled trial. Nutrition Journal. 20(1). 2–2. 23 indexed citations
9.
Jones, Mark, Satomi Okano, David Looke, et al.. (2021). Catheter-associated bloodstream infection in patients with cancer: comparison of left- and right-sided insertions. Journal of Hospital Infection. 118. 70–76. 3 indexed citations
10.
Beesley, Vanessa L., Jane Turner, Raymond J. Chan, et al.. (2020). Supporting patients and carers affected by pancreatic cancer: A feasibility study of a counselling intervention. European Journal of Oncology Nursing. 46. 101729–101729. 13 indexed citations
11.
Mollee, Peter, Satomi Okano, David Looke, et al.. (2020). Catheter-associated bloodstream infections in adults with cancer: a prospective randomized controlled trial. Journal of Hospital Infection. 106(2). 335–342. 14 indexed citations
12.
Atkinson, Victoria, Adnan Khattak, Andrew Haydon, et al.. (2020). Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma. Journal for ImmunoTherapy of Cancer. 8(2). e001681–e001681. 77 indexed citations
13.
Colditz, Michael, et al.. (2020). Surgical series of metastatic cerebral melanoma: Clinical association of resection, BRAF-mutation status, and survival. SHILAP Revista de lepidopterología. 24. 101075–101075.
14.
Burge, Matthew, Belinda Lee, Margaret Lee, et al.. (2018). Previous Bevacizumab and Efficacy of Later Anti–Epidermal Growth Factor Receptor Antibodies in Metastatic Colorectal Cancer: Results From a Large International Registry. Clinical Colorectal Cancer. 17(3). e593–e599. 7 indexed citations
15.
Burge, Matthew, et al.. (2018). Metastatic colorectal cancer during pregnancy: A tertiary center experience and review of the literature. Obstetric Medicine. 12(1). 38–41. 5 indexed citations
16.
Mollee, Peter, Satomi Okano, David Looke, et al.. (2017). Catheter-Associated Bloodstream Infections (CA-BSI) in Adults with Cancer: A Prospective Randomized Controlled Trial. Blood. 130. 4729–4729. 1 indexed citations
17.
Xu, Wen, Mahendra Singh, Hui Yan, Zarnie Lwin, & Melissa Eastgate. (2016). Disseminated disease including intra-cardiac metastasis from intermediate trophoblastic tumor of unspecified subtype, presenting in pregnancy. Gynecologic Oncology Reports. 16. 34–38.
18.
19.
Burge, Matthew, et al.. (2014). Time from diagnosis of rectal adenocarcinoma to commencement of long course chemoradiotherapy (Lccrt) for metropolitan versus rural patients referred to a Queensland tertiary referral hospital. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations
20.
Chan, Bryan, et al.. (2014). Rural Oncology Care Via Teleoncology and Outreach Clinics: Patient and Staff Perspectives and Comparisons. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rangarirai Makuku Breakdown of academic impact, for papers by Alexandra C. Istl Breakdown of academic impact, for papers by Manli Miao Breakdown of academic impact, for papers by Cyril Lervat Breakdown of academic impact, for papers by Sarah Wall Breakdown of academic impact, for papers by Scott Maffett Breakdown of academic impact, for papers by Zhi-ling Yang Breakdown of academic impact, for papers by María Velez Breakdown of academic impact, for papers by Emily S. Andersen Breakdown of academic impact, for papers by Maria Koutsaki
Rankless by CCL
2026